Accuray announces first patient treatments in new zealand with the cyberknife® system, the world's only robotic radiation therapy delivery device

Auckland radiation oncology selected the latest-generation cyberknife s7™ system to deliver precise treatments more quickly, so patients can rapidly return to the activities they enjoy sunnyvale, calif. , jan. 17, 2023 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that auckland radiation oncology (aro) is the first center in new zealand to treat patients with the cyberknife ® system, a robotic radiation therapy device known for delivering treatments with sub-millimeter precision and accuracy in typically 1 to 5 outpatient sessions.
ARAY Ratings Summary
ARAY Quant Ranking